Ligand validation:4IXR

LHG: 1,2-DIPALMITOYL-PHOSPHATIDYL-GLYCEROLE

LHG is a Ligand Of Interest in 4IXR designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4IXR_LHG_A_412	10%	48%	0.289	0.833	1.05	0.98	2	2	0	0	80%	1
4IXR_LHG_a_414	3%	46%	0.411	0.798	1.07	1	2	2	0	0	80%	1
4IXR_LHG_a_417	2%	46%	0.372	0.701	1.09	1.01	2	2	0	0	76%	1
4IXR_LHG_A_415	0%	44%	0.574	0.623	1.08	1.08	2	2	0	0	76%	1
5GTI_LHG_L_101	99%	46%	0.045	0.971	0.91	1.17	2	4	0	0	100%	1
3WU2_LHG_D_409	98%	49%	0.051	0.976	0.84	1.14	2	5	0	0	100%	1
5V2C_LHG_l_101	98%	46%	0.068	0.987	0.91	1.18	2	3	0	0	100%	1
5B66_LHG_D_408	97%	52%	0.056	0.972	0.82	1.03	2	1	0	0	100%	1
8F4C_LHG_D_410	97%	46%	0.056	0.969	0.82	1.24	2	7	0	0	100%	1
5WS6_LHG_d_407	96%	53%	0.063	0.973	0.89	0.91	3	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.